N Chow1, K S Hwang2, S Hurtz3, A E Green4, J H Somme5, P M Thompson6, D A Elashoff7, C R Jack8, M Weiner9, L G Apostolova10. 1. From the School of Medicine (N.C.), University of California, Irvine, Irvine, California. 2. Oakland University William Beaumont School of Medicine (K.S.H.), Rochester Hills, Michigan Departments of Neurology (K.S.H., S.H., L.G.A.). 3. Departments of Neurology (K.S.H., S.H., L.G.A.). 4. Department of Physiology (A.E.G.), Monash University, Melbourne, Australia. 5. Department of Neurology (J.H.S.), Cruces University Hospital, Barakaldo, Spain. 6. Imaging Genetics Center (P.M.T.), Institute for Neuroimaging and Informatics, Keck/University of Southern California School of Medicine, Los Angeles, California Departments of Neurology, Psychiatry, Engineering, Radiology, and Ophthalmology (P.M.T.), University of Southern California, Los Angeles, California. 7. Biostatistics (D.A.E.), University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California. 8. Department of Radiology (C.R.J.), Mayo Clinic and Foundation, Rochester, Minnesota. 9. Department of Radiology and Biomedical Imaging (M.W.), University of California, San Francisco, School of Medicine, San Francisco, California. 10. Departments of Neurology (K.S.H., S.H., L.G.A.) lapostolova@mednet.ucla.edu.
Abstract
BACKGROUND AND PURPOSE: Prior MR imaging studies, primarily at 1.5T, established hippocampal atrophy as a biomarker for Alzheimer disease. 3T MR imaging offers a higher contrast and signal-to-noise ratio, yet distortions and intensity uniformity are harder to control. We applied our automated hippocampal segmentation technique to 1.5T and 3T MR imaging data, to determine whether hippocampal atrophy detection was enhanced at 3T. MATERIALS AND METHODS: We analyzed baseline MR imaging data from 166 subjects from the Alzheimer's Disease Neuroimaging Initiative-1 (37 with Alzheimer disease, 76 with mild cognitive impairment, and 53 healthy controls) scanned at 1.5T and 3T. Using multiple linear regression, we analyzed the effect of clinical diagnosis on hippocampal radial distance, while adjusting for sex. 3D statistical maps were adjusted for multiple comparisons by using permutation-based statistics at a threshold of P < .01. RESULTS: Bilaterally significant radial distance differences in the areas corresponding to the cornu ammonis 1, cornu ammonis 2, and subiculum were detected for Alzheimer disease versus healthy controls and mild cognitive impairment versus healthy controls at 1.5T and more profoundly at 3T. Comparison of Alzheimer disease with mild cognitive impairment did not reveal significant differences at either field strength. Subjects who converted from mild cognitive impairment to Alzheimer disease within 3 years of the baseline scan versus nonconverters showed significant differences in the area corresponding to cornu ammonis 1 of the right hippocampus at 3T but not at 1.5T. CONCLUSIONS: While hippocampal atrophy patterns in diagnostic comparisons were similar at 1.5T and 3T, 3T showed a superior signal-to-noise ratio and detected atrophy with greater effect size compared with 1.5T.
BACKGROUND AND PURPOSE: Prior MR imaging studies, primarily at 1.5T, established hippocampal atrophy as a biomarker for Alzheimer disease. 3T MR imaging offers a higher contrast and signal-to-noise ratio, yet distortions and intensity uniformity are harder to control. We applied our automated hippocampal segmentation technique to 1.5T and 3T MR imaging data, to determine whether hippocampal atrophy detection was enhanced at 3T. MATERIALS AND METHODS: We analyzed baseline MR imaging data from 166 subjects from the Alzheimer's Disease Neuroimaging Initiative-1 (37 with Alzheimer disease, 76 with mild cognitive impairment, and 53 healthy controls) scanned at 1.5T and 3T. Using multiple linear regression, we analyzed the effect of clinical diagnosis on hippocampal radial distance, while adjusting for sex. 3D statistical maps were adjusted for multiple comparisons by using permutation-based statistics at a threshold of P < .01. RESULTS: Bilaterally significant radial distance differences in the areas corresponding to the cornu ammonis 1, cornu ammonis 2, and subiculum were detected for Alzheimer disease versus healthy controls and mild cognitive impairment versus healthy controls at 1.5T and more profoundly at 3T. Comparison of Alzheimer disease with mild cognitive impairment did not reveal significant differences at either field strength. Subjects who converted from mild cognitive impairment to Alzheimer disease within 3 years of the baseline scan versus nonconverters showed significant differences in the area corresponding to cornu ammonis 1 of the right hippocampus at 3T but not at 1.5T. CONCLUSIONS: While hippocampal atrophy patterns in diagnostic comparisons were similar at 1.5T and 3T, 3T showed a superior signal-to-noise ratio and detected atrophy with greater effect size compared with 1.5T.
Authors: C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen Journal: Neurology Date: 1999-04-22 Impact factor: 9.910
Authors: Liana G Apostolova; Rebecca A Dutton; Ivo D Dinov; Kiralee M Hayashi; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson Journal: Arch Neurol Date: 2006-05
Authors: Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson Journal: Neuroimage Date: 2008-11-08 Impact factor: 6.556
Authors: John G Csernansky; Julia Hamstra; Lei Wang; Daniel McKeel; Joseph L Price; Mokhtar Gado; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2004 Oct-Dec Impact factor: 2.703
Authors: D P Devanand; G Pradhaban; X Liu; A Khandji; S De Santi; S Segal; H Rusinek; G H Pelton; L S Honig; R Mayeux; Y Stern; M H Tabert; M J de Leon Journal: Neurology Date: 2007-03-13 Impact factor: 9.910
Authors: Liana G Apostolova; Jonathan H Morra; Amity E Green; Kristy S Hwang; Christina Avedissian; Ellen Woo; Jeffrey L Cummings; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson Journal: Neuroimage Date: 2010-01-18 Impact factor: 6.556
Authors: Lei Wang; Jeffrey S Swank; Irena E Glick; Mokhtar H Gado; Michael I Miller; John C Morris; John G Csernansky Journal: Neuroimage Date: 2003-10 Impact factor: 6.556
Authors: April J Ho; Xue Hua; Suh Lee; Alex D Leow; Igor Yanovsky; Boris Gutman; Ivo D Dinov; Natasha Leporé; Jason L Stein; Arthur W Toga; Clifford R Jack; Matt A Bernstein; Eric M Reiman; Danielle J Harvey; John Kornak; Norbert Schuff; Gene E Alexander; Michael W Weiner; Paul M Thompson Journal: Hum Brain Mapp Date: 2010-04 Impact factor: 5.038
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2017-03-22 Impact factor: 21.566
Authors: Marina Buciuc; Alexandra M Wennberg; Stephen D Weigand; Melissa E Murray; Matthew L Senjem; Anthony J Spychalla; Bradley F Boeve; David S Knopman; Clifford R Jack; Kejal Kantarci; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Jennifer L Whitwell; Keith A Josephs Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Katherine Reiter; Kristy A Nielson; Sally Durgerian; John L Woodard; J Carson Smith; Michael Seidenberg; Dana A Kelly; Stephen M Rao Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Nikhil Bhagwat; Jon Pipitone; Aristotle N. Voineskos; M. Mallar Chakravarty Journal: J Psychiatry Neurosci Date: 2019-07-01 Impact factor: 6.186